Virtual Medical Academy

Overview

This webinar focuses on recent developments in CAR-T cell therapy and its clinical applications in hematologic oncology, along with approaches to full-cycle care and management for oncology patients.
The program includes expert-led presentations and interactive discussions aimed at sharing clinical experience and current practices in the management of hematologic malignancies.

This Activity for

Nursing and Midwifery
Resident / Fellow
Physician
Pharmacy
Public and Community Health
Clinical Pharmacy
Emergency Medical Services

What I will learn?

By the end of this activity, participants will be able to:

- Identify eligible patients for CAR-T therapy using current guidelines and apply appropriate referral criteria in at least 80% of clinical scenarios by the end of the activity.

- Explain the mechanism of action and recent advances in CAR-T therapy and incorporate this knowledge into clinical decision-making during practice.

- Recognize and manage CAR-T–related toxicities, including CRS and ICANS, using standardized, evidence-based protocols in

simulated or real clinical cases.

- Develop and implement multidisciplinary care plans covering all phases of CAR-T treatment, from pre-infusion assessment to long-term follow-up, within clinical workflows.

- Demonstrate effective patient communication and shared decision-making skills by clearly discussing treatment options, benefits, risks, and expectations.

Activity Details

Pro. HAO Siguo
MD, PhD

Chief Hematology Consultant
at Jiahui International Hospital.
Director and Academic Leader
of the Department of
Hematology at Xinhua Hospital
affiliated to Shanghai Jiao Tong
University School of Medicine.

Dr. XUAN Linli
MD
Chief of Medical Oncology at
Jiahui International Cancer
Center (JICC). With 30 years of
experience in cancer research
and clinical practice.